SUMMARY
Mushrooms are a low calorie food with very little fat and are highly suitable for obese persons. The
objective of the present investigation was to study the interaction of aqueous extract of P. pulmonarius
(called PP-aqu) with acarbose on serum glucose levels, and on the oral glucose tolerance test (OGTT)
in alloxan induced diabetic mice. PP-aqu (500 mg/kg), acarbose (50 mg/kg) and their combination
were administered orally in alloxan (70 mg/kg i.v.) induced diabetic mice. In the acute study, the
serum glucose level was estimated at 0, 2, 4, 6 and 24 h after drug administration. The subacute study
involved repeated administration of the drugs for 28 days, a serum glucose level estimation at 7, 14, 21
and 28 days and recording of the body weights of the mice. In the OGTT, D-glucose (2.5 g/kg) was
administered in diabetic mice half an hour after pre-treatment with PP-aqu (500 mg/kg), acarbose (50
mg/kg) and their combination. Serum glucose levels were estimated 30 min prior to glucose
administration and at 0, 30, 60 and 120 min after glucose loading. The antihyperglycaemic effects of
PP-aqu and acarbose alone were similar; i.e. the onset was 2 h, the peak effect was 6 h but the effect
waned at 24 h. The effect of the combination of PP-aqu with acarbose was however different, as serum
glucose was lower at 24 h. In the subacute study, repeated administration (once a day for 28 days) of
the acarbose, PP-aqu and combination caused a significant (P<0.001) reduction in the serum glucose
level as compared to the vehicle treated group. Combination treatment prevented a decrease in the
body weight of the diabetic mice. In the OGTT test, the combination of PP-aqu with acarbose
increased the glucose threshold at 120 min after the administration of glucose. The combination
treatment of PP-aqu with acarbose produced a more synergistic antihyperglycaemic effect than either
drug alone.
KEY WORDS
P. pulmonarius; acarbose; alloxan diabetes; serum glucose; OGTT
REFERENCES
Abdel-Barry JA, Abdel-Hassan IA, Al-Hakiem
MH: Hypoglycaemic and antihyperglycaemic
effects of Trigonella foenum-graecum leaf in
normal and alloxan induced diabetic rats. J
Ethnopharmacol 58:149-155, 1997.
Akhtar MS, Khan QM, Khaliq T: Effects of
Portulaca oleracae (Kulfa) and Taraxacum
officinale (Dhudhal) in normoglycaemic and
alloxan-treated hyperglycaemic rabbits. J Pak
Med Assoc 35:207-210, 1985.
Awang DV, Fugh-Berman A: Herbal interactions
with cardiovascular drugs. J Cardiovasc Nurs
16:64-70, 2002.
Badole SL, Shah SN, Patel NN, Thakurdesai PA,
Bodhankar SL: Hypoglycemic activity of
aqueous extract of Pleurotus pulmonarius (Fr.)
Quel.-Champ in alloxan induced diabetic mice.
Pharm Biol 44:421-425, 2006a.
Badole SL, Bodhankar SL, Thakurdesai PA: Study
of interaction of aqueous extract of Pleurotus
pulmonarius (Fr.) Quel.-Champ with
rosiglitazone in alloxan induced diabetic mice.
Pharmacologyonline 3:64-72, 2006b.
Badole SL, Bodhankar SL, Thakurdesai PA: Study
of interaction of aqueous extract of Pleurotus
pulmonarius (Fr.) Quel.-Champ with glyburide
in alloxan induced diabetic mice. Evid Compl
Altern Med (e-CAM) 2007. (Article online.)
Bano Z: The Nutritive value of mushrooms. First
Symposium on Survey and Cultivation of
Edible Mushrooms of India, Regional
Research Laboratory, Jammu 1976, pp. 148-169.
Bressler R: Herb-drug interactions: interactions
between kava and prescription medications.
Geriatrics 60:24-25, 2005.
Cheung PC, Lee MY: Fractionation and
characterization of mushroom dietary fiber
(nonstarch polysaccharides) as potential
nutraceuticals from sclerotia of Pleurotus
tuberregium (Fries) singer. J Agric Food
Chem 48:3148-3151, 2000.
Coxeter PD, McLachlan AJ, Duke CC, Roufogalis
BD: Herb-drug interactions: an evidence based
approach. Curr Med Chem 11:1513-1525, 2004.
Ewart RB, Kornfeld S, Kipnis DM: Effect of
lectins on hormone release from isolated rat
islets of langerhans. Diabetes 24:705-714, 1975.
Flegg PB, Maw GA: Mushroom and their possible
contribution to world protein needs.
Mushroom J 48:396-405, 1976.
Food and Agriculture Organization of the United
Nations. Food composition table for use in
Africa. Vol ix. Bethesda, Md.: US Dept.of
Health, Education, and Welfare, Nutrition
Program, and Food Consumption and Planning
Branch, Food and Agriculture Organization of
the United Nations 1968.
Fu H, Shieh DE: Antioxidant and free radical
scavenging activities of edible mushrooms. J
Food Lipids 9:35-46, 2002.
Fugh-Berman A, Ernst E: Herb-drug interactions:
review and assessment of report reliability. Br.
J Clin Pharmacol 52:587-595, 2001.
Gray AM, Flatt PR: Insulin-releasing and insulinlike
activity of Agaricus campestris
(mushroom). J Endocrinol 157:259-266, 1998.
Gumieniczek A, Hopkala H, Rolinski J, Bojarska-Junak A: Antioxidative and anti-inflammatory
effects of repaglinide in plasma of diabetic
animals. Pharmacol Res 52:162-166, 2005.
Hikino H, Takahashi M, Konno C, Ishimori A,
Kawamura T, Namiki T: Effect of glycans of
Saccharum officinarum on carbohydrate and
lipid metabolism of rats. J Ethnopharmacol
14:261-268, 1985.
Ishikawa Y, Morimoto K, Hamasaki T:
Flavoglaucin, a metabolite of Eurotium
Chevalieri, its antioxidation and synergism
with tocopherol. J Am Oil Chem Soc
61:1864-1868, 1984.
Izzo AA: Herb-drug interactions: an overview of
the clinical evidence. Fundam Clin
Pharmacol 19:1-16, 2005.
Kelly KM: Complementary and alternative medical
therapies for children with cancer. Eur J
Cancer 40:2041-2046, 2004.
Khanna P, Garcha HS: Pleurotus mushroom - A
source of food protein. Mushroom News Lett
Tropics 4:9-14, 1984.
Konno S, Tortorelis DG, Fullerton SA, Samadi
AA, Hettiarachchi J, Tazaki H: A possible
hypoglycaemic effect of maitake mushroom on
Type 2 diabetic patients. Diabet Med 18:1010, 2001.
Kusano S, Abe H, Tamura H: Isolation of
antidiabetic components from white-skinned
sweet potato (Ipomoea batatas L.). Biosci
Biotechnol Biochem 65:109-114, 2001.
Latha M and Pari L: Antihyperglycaemic effect of
Cassia auriculata in experimental diabetes and
its effects on key metabolic enzymes involved
in carbohydrated metabolism. Clin Exp
Pharmacol Physiol 30:38-43, 2003.
Lebovitz HE: Alpha-glucosidase inhibitors as
agents in the treatment of diabetes. Diabetes
Rev 6:132-145, 1998.
Lin YC, Bioteau AB, Ferrari LR, Berde CB: The
use of herbs and complementary and
alternative medicine in pediatric preoperative
patients. J Clin Anesth 16:4-6, 2004.
Lindequist U, Niedermeyer TH, Julich WD: The
pharmacological potential of mushrooms.
Evid Based Complement Alternat Med 2:285-299, 2005.
Manohar V, Talpur NA, Echard BW, Lieberman S,
Preuss HG: Effects of a water-soluble extract
of maitake mushroom on circulating
glucose/insulin concentrations in KK mice.
Diabetes Obes Metab 4:43-48, 2002.
Mau JL, Lin HC, Song SF: Antioxidant properties
of several specialty mushrooms. Food Res
Intern 35:519-526, 2002.
Miles PG, Chang ST: Mushroom Biology: Concise
Basics and Current Development. World
Scientific Publishing Company, New York
1997.
Pan J, Chan EK, Cheta D, Schranz V, Charles MA:
The effects of nicotinamide and glimepiride on
diabetes prevention in BB rats. Life Sci 57:1525-1532, 1995.
Poppenga RH: Herbal medicine: potential for
intoxication and interactions with conventional
drugs. Clin Tech Small Anim Pract 17:6-18, 2002.
Ramkumar KM, Latha M, Venkateswaran S, Pari
L, Ananthan R, Bai VN: Modulatory effect of
Gymnema montanum leaf extract on brain
antioxidant status and lipid peroxidation in
diabetic rats. J Med Food 7:366-371, 2004.
Raptis SA, Dimitriadis GD: Oral hypoglycemic
agents: insulin secretogogues, alphaglucosidase
inhibitors and insulin sensitizers.
Exp Clin Endocrinol Diabetes 109 (Suppl 2):265-287, 2001.
Reddy SV, Tiwari AK, Kumar US, Rao RJ, Rao
JM: Free radical scavenging, enzyme
inhibitory constituents from antidiabetic
Ayurvedic medicinal plant Hydnocarpus
wightiana Blume. Phytother Res 19:277-281, 2005.
Sabu MC, Kuttan R: Antidiabetic activity of Aegle
marmelos and its relationship with its
antioxidant properties. Ind J Physiol
Pharmacol 48:81-88, 2004.
Samane S, Noel J, Charrouf Z, Amarouch H,
Haddad PS: Insulin-sensitizing and
antiproliferative effects of Argania spinosa
seed extracts. Evid Based Complement
Alternat Med 3:317-327, 2006.
Siemianowicz K, Gminski J, Telega A, Wojcik A,
Posielezna B, Grabowska-Bochenek R: Blood
antioxidant parameters in patients with diabetic
retinopathy. Int J Mol Med 14:433-437, 2004.
Singh M, Varshneya C, Telang RS, Srivastava AK:
Alteration of pharmacokinetics of
oxytetracycline following oral administration
of Piper longum in hens. J Vet Sci 6:197-200, 2005.
Swanston-Flatt SK, Day C, Flatt PR, Gould BJ,
Bailey CJ: Glycaemic effects of traditional
European plant treatments for diabetes. Studies
in normal and streptozotocin diabetic mice.
Diabetes Res 10:69-73, 1989.
Talpur N, Echard B, Dadgar A, Aggarwal S,
Zhuang C, Bagchi D: Effects of Maitake
mushroom fractions on blood pressure of
Zucker fatty rats. Res Commun Mol Pathol
Pharmacol 112:68-82, 2002a.
Talpur NA, Echard BW, Fan AY, Jaffari O, Bagchi
D, Preuss HG: Antihypertensive and metabolic
effects of whole Maitake mushroom powder
and its fractions in two rat strains. Mol Cell
Biochem 237:129-136, 2002b.
Talpur N, Echard BW, Yasmin T, Bagchi D, Preuss
HG: Effects of niacin-bound chromium,
Maitake mushroom fraction SX and (-)-
hydroxycitric acid on the metabolic syndrome
in aged diabetic Zucker fatty rats. Mol. Cell.
Biochem. 252:369-377, 2003.
Takahasi M, Konno C, Hikino H: Isolation and
hypoglycemic activity of Anemorans A, B, C
and D, glycans of Anemarsrhema
asphodelcides rhizomes. Planta Med 51:100-102, 1985.
Tribe I, Tosco U: The World of Mushrooms. Vol.
viii. Orbis Publishing, London 1973.
Windholz M: The Merck Index: An Encyclopedia
of Chemicals, Drugs and Biologicals 10th ed.
Merck & Co., New Jersey 1983.
Woodward KN: The potential impact of the use of
homeopathic and herbal remedies on
monitoring the safety of prescription products.
Hum Exp Toxicol 24:219-233, 2005.
Wright T: Medicinal mushrooms. In Wright R
(ed.): Nutraceutical World, Rodman
publishing, Ramsay, New Jersey 2004, pp. 26-29.
Yang JH, Lin H, C, Mau JL: Antioxidant properties
of several commercial mushrooms. Food
Chem 77:229-235, 2002.
Zeng C, Liu Y, Wang Z, He D, Huang L, Yu P:
Activation of D3 dopamine receptor decreases
angiotensin II type 1 receptor expression in rat
renal proximal tubule cells. Circ Res 99:494-500, 2006.
|
CITED
Roupas P, Keogh J, Noakes M, Margetts C, Taylor P. The role of edible mushrooms in health: Evaluation of the evidence. J Functional Foods. 4: 687-709, 2012.
De Silva DD, Rapior S, Hyde KD, Bahkali AH. Medicinal mushrooms in prevention and control of diabetes mellitus. Fungal Diversity. 56: 1-29, 2012.
Vamanu E, Ene M, Pelinescu D, Sarbu I, Vamanu A, Nita S. Determination of antioxidant and antimicrobial properties of alcoholic extract from Pleurotus ostreatus M2191 mycelium obtained in the presence of various nitrogen sources. Rev Chim. 62: 1189-1194, 2011.
Badole SL, Bodhankar SL. Effect of concomitant administration of aqueous extract of Pleurotus pulmonarius and metformin in diabetic mice. J Complementary and Integrative Med. 5 No 27, 2008.
Badole SL, Thakurdesai PA, Bodhankar SL. Antioxidant activity of aqueous extract of Pleurotus pulmonarius (Fries) quel-champ. Pharmacologyonline. 2: 26-41, 2008.
|
